LAMEA Healthcare CRO Services Market Size

LAMEA Healthcare CRO Services Market By Service Type (Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services) By End User (Pharmaceutical companies, Medical Device Companies and Academic Institutes) By Therapeutic Area (Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas) By Country, Industry Analysis and Forecast, 2019 - 2025

LAMEA Healthcare CRO Services Market By Service Type (Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services) By End User (Pharmaceutical companies, Medical Device Companies and Academic Institutes) By Therapeutic Area (Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas) By Country, Industry Analysis and Forecast, 2019 - 2025

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : April-2020 | Number of Pages : 108 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the LAMEA Healthcare CRO Services Market

The Latin America, Middle East and Africa Healthcare CRO Services Market would witness market growth of 10% CAGR during the forecast period (2019-2025). Latin America is another important market, in addition to these regions. This is due to the region's improved research infrastructure and rising demand for novel pharmaceutical and biopharmaceutical drugs. Brazil holds the largest share of the Latin American market, owing to the country's growing R&D activities. Growing investment in R&D projects, preference for outsourcing activities due to time and cost constraints and the expiration of patents in the healthcare sector are key factors expected to drive the market in the years to come. Contract research outsourcing partnerships provide advanced facilities, and thus government entities tend to assign projects to contract research organizations (CROs), thereby promoting market demand.

Increasing pressure on drug developers in terms of clinical data management, regulatory environments, and strict safety requirements is expected to increase demand within the healthcare sector for contract research organizations. In this marketplace, models such as transactional partnerships, FSP/Multi-FSP, and alliances are widespread and are being adopted by drug developers.

Healthcare is a very dynamic sector and delivery of service is fragmented care. Quality should also be a growing model for addressing the health care needs of all groups. Quality improvement is the process solution to the operational challenges of the organization. The initiative to tackle healthcare efficiency has become a global trend. The demand of the time is a quality revolution in the delivery of care with the patient at the center and the facilities around it.

Based on Service Type, the market is segmented into Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services. Based on End User, the market is segmented into Pharmaceutical companies, Medical Device Companies and Academic Institutes. Based on Therapeutic Area, the market is segmented into Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: Healthcare CRO Services Market in LAMEA is expected to register a CAGR of 10% during the forecast period (2019-2025)

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.

Scope of the LAMEA Healthcare CRO Services Market Analysis

Market Segmentation:

By Service Type

  • Clinical Research Services
  • Early Phase Development
  • Laboratory Services and
  • Consulting Services

By End User

  • Pharmaceutical companies
  • Medical Device Companies and
  • Academic Institutes

By Therapeutic Area

  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Diabetes
  • Metabolic Diseases
  • Infectious Diseases and
  • Other therapeutic areas

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Pharmaceutical Product Development, Inc.
  • Parexel International Corporation (Pamplona Capital Management)
  • Charles River Laboratories International, Inc.
  • ICON PLC
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Syneos Health, Inc.
  • Pharmaron Beijing Co., Ltd.
  • GVK Biosciences Private Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Healthcare CRO Services Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities